Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy is a research paper published in Cancer Discovery (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH NIAMS
Grant: U01 AR077511
NIH NCI
Grant: P30 CA008748
NIH
Grant: R35 CA197633
NIH
Grant: P01 CA244118
NIH
Grant: P30 CA016042
NIAID NIH HHS
Grant: U01 AI147462
National Institutes of Health
Grant: 3P30CA016042-35S3
Cancer Center Support Grant
National Institutes of Health
Grant: 1U01AR077511-01
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 1P01CA244118-01A1
Combination Therapies to Defeat Melanoma Resistance
National Institutes of Health
Grant: 2R35CA197633-08
Next Generation Cancer Immunotherapies to Defeat Melanoma
FWCI
1.26
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals